Diadema Partners LP Olema Pharmaceuticals, Inc. Put Options Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding OLMA
# of Institutions
136Shares Held
64.4MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$32.2 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$31.7 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$24.9 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$18.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$16.2 Million0.45% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $190M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...